Simplifying Global Compliance
FDAnews Drug Daily Bulletin
J&J Unit Aims to Thwart Sandoz’s Generic Doribax
Dec. 16, 2011
Johnson & Johnson unit Janssen Pharmaceuticals slapped Sandoz with a patent infringement lawsuit in New Jersey federal court in an effort to keep the company from marketing its own version of the injectable antibiotic Doribax.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing